In vitro susceptibility testing of clinical isolates of Nocardia
- 15 November 1993
- journal article
- research article
- Published by Elsevier in Clinical Microbiology Newsletter
- Vol. 15 (22) , 169-172
- https://doi.org/10.1016/0196-4399(93)90044-n
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- NocardiosisSeminars in Respiratory and Critical Care Medicine, 1992
- Comparison of Species Ditribution and Antimicrobial Susceptibility of Aerobic Actinomycetes from Clinical SpecimensClinical Infectious Diseases, 1990
- In-vitro susceptibility testing of Nocardia spp. and its taxonomic implicationJournal of Antimicrobial Chemotherapy, 1988
- In vitro susceptibilities of Nocardia species to newer antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1988
- Susceptibility testing of nocardia species for the clinical laboratoryDiagnostic Microbiology and Infectious Disease, 1988
- Cure of Brain Abscess Caused by Nocardia asteroides Resistant to Multiple AntibioticsSouthern Medical Journal, 1988
- Susceptibility of Nocardia asteroides to new quinolones and beta-lactamsAntimicrobial Agents and Chemotherapy, 1987
- In vitro susceptibility of Nocardia asteroides to 25 antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1984
- Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactamsAntimicrobial Agents and Chemotherapy, 1983
- Differences Among Nocardia spp. in Susceptibility to Aminoglycosides and β-Lactam Antibiotics and Their Potential Use in TaxonomyAntimicrobial Agents and Chemotherapy, 1983